PharmAthene Canada Inc.

PharmAthene Canada Inc.

Saint-laurent, QC

Company Overview

Nexia Biotechnologies Inc. (TSE: NXB) develops and manufactures complex recombinant proteins in the form of biomaterial and biopharmaceutical products with industrial and medical applications. The Companys most advanced performance fiber product under development, BioSteel, is based on spider silk proteins. BioSteel products will include medical devices (wound closure systems) and advanced industrial performance products (military and aerospace applications). The Companys lead biopharmaceutical product under development is a version of human tissue plasminogen activator (htPA), a commercially available thrombolytic protein drug used to treat heart attacks and ischemic strokes.

Company Information

Physical Address

7150 Alexander-Fleming St
Saint-laurent, QC H4S 2C8
CA

Mailing Address

7150 Alexander-Fleming St
Saint-laurent, QC H4S 2C8
CA

Phone

Phone: Show phone

Toll Free: Show toll free

Fax: Show fax

Online

Email: -

Website: http://www.pharmathene.com

Additional Details

Legal Name: PharmAthene Canada Inc.

Number of Employees: 85

Country of Ownership:

CA

Technology Profile:

Nexia manufactures these novel and rare recombinant proteins using transgenic dairy animals. Our platform technology is the BELE (Breed Early, Lactate Early) goat which features an ideal blend of unprecedented speed (8 months from DNA to rprotein in milk) and modest cost. In 1999, Nexia produced the worlds first transgenic goats carrying a spider silk gene. Nexia is currently in the manufacturing scale-up phase of producing BioSteel performance fibers for medical device industrial applications. BioSteel proteins have been successfully produced in the milk of transgenic goats.

Contacts

Lisa Gloutney

Title: Corporate Communications

Phone: Show phone

Fax: Show fax

Email: Show email

Jim Mcdonald

Title: Executive Vice-President, Corp. Devel.

Area of Responsibility: Management Executive

Phone: Show phone

Fax: Show fax

Email: Show email

Harvey Wilgus

Title: VP Research and Development

Phone: Show phone

Fax: Show fax

Email: Show email

Jeffrey D. Turner

Title: President & CEO

Area of Responsibility: Management Executive

Phone: Show phone

Fax: Show fax

Email: Show email

Edward Wein

Title: Vice-President, Business Development

Area of Responsibility: Management Executive

Phone: Show phone

Fax: Show fax

Email: Show email

Dana Rath

Title: Vice-President, Finance & Administration

Area of Responsibility: Finance/Accounting

Phone: Show phone

Fax: Show fax

Email: Show email

Costas N. Karatzas

Title: Vice-President, R&D

Area of Responsibility: Research/Development/Engineering

Phone: Show phone

Fax: Show fax

Email: Show email

Services

  • Recombinant Protein Production

    Nexia's transgenic BELE goats production system is the fastest and most cost effective technique available to produce rare and complex recombinant proteins.

Products

  • Biosteel

Additional Information

NAICS:

541710